In order to evaluate patients BMSCs population, we verify that MSCs derived from BS patient have similar levels of CD45-, CD14-, CD34-, CD31-, CD29+, CD13+, CD90+, CD73+, and CD105+ surface markers compared with OI and healthy donors MSCs (Additional file 2). This evidence concerns the gene ANPEP and osteogenesis imperfecta.